Skip to main content
Premium Trial:

Request an Annual Quote

Fujitsu Biosciences Licenses BioMedCache Software to NeurAxon

NEW YORK, Feb. 22 (GenomeWeb News) - Fujitsu America's Biosciences group said today that it has licensed its BioMedCache automated docking and molecular modeling software to Canadian drug maker NeurAxon.

 

Under the terms of the agreement, NeurAxon will use the software's ActiveSite module to design small-molecule inhibitors of protein targets, Fujitsu said.

 

Financial terms of the deal were not disclosed.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.